These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25211284)

  • 41. [Congenital toxoplasmosis and seroconversion at the end of pregnancy: clinical observations].
    Luyasu V; Bauraind O; Bernard P; Bietlot Y; Brasseur C; Englebert J; Fiasse L; Givron O; Longueville E; Melard JL; Michel M; Wacquez M
    Acta Clin Belg; 1997; 52(6):381-7. PubMed ID: 9489134
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of toxoplasmosis in the pregnant mother and newborn child.
    Stray-Pedersen B
    Scand J Infect Dis Suppl; 1992; 84():23-31. PubMed ID: 1290070
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of adverse reactions of spiramycin versus pyrimethamine/sulfadiazine treatment of toxoplasmosis in pregnancy: is spiramycin really the drug of choice for unproven infection of the fetus?
    Prasil P; Sleha R; Kacerovsky M; Bostik P
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2215377. PubMed ID: 37217458
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic problems and postnatal follow-up in congenital toxoplasmosis.
    Mazzola A; Casuccio A; Romano A; Schimmenti MG; Titone L; Di Carlo P
    Minerva Pediatr; 2007 Jun; 59(3):207-13. PubMed ID: 17519865
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Termination of pregnancy for maternal toxoplasmosis.
    Berrebi A; Kobuch WE; Bessieres MH; Bloom MC; Rolland M; Sarramon MF; Roques C; Fournié A
    Lancet; 1994 Jul; 344(8914):36-9. PubMed ID: 7912304
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Toxoplasmosis retinochorioiditis, a therapy comparison between spiramycin and pyrimethamine/sulfadiazine].
    Hacker M; Richter R; Gümbel H; Richter T; Ohrloff C
    Klin Monbl Augenheilkd; 1998 Feb; 212(2):84-7. PubMed ID: 9577806
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical experience on treating Toxoplasma gondii infection during pregnancy by using acetyl spiramycin combined with azithromycin].
    Tang HX; Xiong XF; Qin ZQ
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2013 Oct; 25(5):555-6. PubMed ID: 24490384
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sulfadiazine plasma concentrations in women with pregnancy-acquired compared to ocular toxoplasmosis under pyrimethamine and sulfadiazine therapy: a case-control study.
    Reiter-Owona I; Hlobil H; Enders M; Klarmann-Schulz U; Gruetzmacher B; Rilling V; Hoerauf A; Garweg JG
    Eur J Med Res; 2020 Nov; 25(1):59. PubMed ID: 33228795
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ophthalmic outcomes after prenatal and postnatal treatment of congenital toxoplasmosis.
    Brézin AP; Thulliez P; Couvreur J; Nobré R; Mcleod R; Mets MB
    Am J Ophthalmol; 2003 Jun; 135(6):779-84. PubMed ID: 12788116
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment.
    Hohlfeld P; Daffos F; Thulliez P; Aufrant C; Couvreur J; MacAleese J; Descombey D; Forestier F
    J Pediatr; 1989 Nov; 115(5 Pt 1):765-9. PubMed ID: 2681638
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The prevalence of Toxoplasma gondii infection among 2016 pregnant women and their children in the Institute of Mother and Child in Warsaw].
    Niemiec KT; Raczyński P; Markiewicz K; Leibschang J; Ceran A
    Wiad Parazytol; 2002; 48(3):293-9. PubMed ID: 16888975
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy.
    Wallon M; Liou C; Garner P; Peyron F
    BMJ; 1999 Jun; 318(7197):1511-4. PubMed ID: 10356003
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Toxoplasmosis].
    Maeda T
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():603-7. PubMed ID: 12722288
    [No Abstract]   [Full Text] [Related]  

  • 54. Toxoplasmosis screening during pregnancy in France: Opinion of an expert panel for the CNGOF.
    Picone O; Fuchs F; Benoist G; Binquet C; Kieffer F; Wallon M; Wehbe K; Mandelbrot L; Villena I
    J Gynecol Obstet Hum Reprod; 2020 Sep; 49(7):101814. PubMed ID: 32428782
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between the risk of congenital toxoplasmosis and the classification of toxoplasmosis in pregnant women and prenatal treatment in Brazil, 1994-2009.
    Campello Porto L; Duarte EC
    Int J Infect Dis; 2012 Jul; 16(7):e480-6. PubMed ID: 22522069
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Toxoplasmosis.
    Beazley DM; Egerman RS
    Semin Perinatol; 1998 Aug; 22(4):332-8. PubMed ID: 9738998
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In utero treatment of toxoplasmic fetopathy with the combination pyrimethamine-sulfadiazine.
    Couvreur J; Thulliez P; Daffos F; Aufrant C; Bompard Y; Gesquière A; Desmonts G
    Fetal Diagn Ther; 1993; 8(1):45-50. PubMed ID: 8452648
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Azithromycin reduces ocular infection during congenital transmission of toxoplasmosis in the Calomys callosus model.
    Lopes CD; Silva NM; Ferro EA; Sousa RA; Firminot ML; Bernardes ES; Roque-Barreira MC; Pena JD
    J Parasitol; 2009 Aug; 95(4):1005-10. PubMed ID: 20050006
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Prevention and treatment of materno-fetal toxoplasmosis].
    Fortier B; Ajana F; Pinto de Sousa MI; Aissi E; Camus D
    Presse Med; 1991 Sep; 20(29):1374-83. PubMed ID: 1835012
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres.
    Gras L; Wallon M; Pollak A; Cortina-Borja M; Evengard B; Hayde M; Petersen E; Gilbert R;
    Acta Paediatr; 2005 Dec; 94(12):1721-31. PubMed ID: 16421031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.